Healthcare provider profile · identity verified

Aaron Glenney

Internal Medicine · AMESBURY, MA · NPI 1932465390

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	432	128
Lisinopril	Lisinopril	358	101
Amlodipine Besylate	Amlodipine Besylate	259	84
Omeprazole	Omeprazole	252	78
Albuterol Sulfate Hfa	Albuterol Sulfate	247	67
Simvastatin	Simvastatin	246	66
Levothyroxine Sodium	Levothyroxine Sodium	230	75
Metoprolol Succinate	Metoprolol Succinate	202	66
Gabapentin	Gabapentin	186	52
Metformin Hcl	Metformin Hcl	181	56
Trazodone Hcl	Trazodone Hcl	166	45
Lorazepam	Lorazepam	146	49
Eliquis	Apixaban	131	34
Losartan Potassium	Losartan Potassium	130	46
Tamsulosin Hcl	Tamsulosin Hcl	116	39
Furosemide	Furosemide	110	37
Sertraline Hcl	Sertraline Hcl	101	23
Hydrochlorothiazide	Hydrochlorothiazide	97	33
Metformin Hcl Er	Metformin Hcl	92	32
Pravastatin Sodium	Pravastatin Sodium	92	27
Fluticasone Propionate	Fluticasone Propionate	90	33
Rosuvastatin Calcium	Rosuvastatin Calcium	87	26
Pantoprazole Sodium	Pantoprazole Sodium	78	26
Atenolol	Atenolol	77	21
Zolpidem Tartrate	Zolpidem Tartrate	77	18
Citalopram Hbr	Citalopram Hydrobromide	75	20
Metoprolol Tartrate	Metoprolol Tartrate	75	27
Allopurinol	Allopurinol	71	24
Clonazepam	Clonazepam	67	14
Escitalopram Oxalate	Escitalopram Oxalate	57	17
Fluoxetine Hcl	Fluoxetine Hcl	53	13
Famotidine	Famotidine	52	18
Alprazolam	Alprazolam	50	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	19
Montelukast Sodium	Montelukast Sodium	49	16
Ibuprofen	Ibuprofen	47	14
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	45	suppressed
Ventolin Hfa	Albuterol Sulfate	43	11
Clopidogrel	Clopidogrel Bisulfate	41	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	40	11
Glipizide Er	Glipizide	39	11
Quetiapine Fumarate	Quetiapine Fumarate	39	12
Nystatin	Nystatin	38	14
Diazepam	Diazepam	34	12
Potassium Chloride	Potassium Chloride	34	13
Bupropion Xl	Bupropion Hcl	33	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Finasteride	Finasteride	30	suppressed
Spironolactone	Spironolactone	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Duloxetine Hcl	Duloxetine Hcl	29	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	29	suppressed
Warfarin Sodium	Warfarin Sodium	29	11
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Gemfibrozil	Gemfibrozil	26	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Jardiance	Empagliflozin	23	suppressed
Naproxen	Naproxen	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Irbesartan	Irbesartan	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	suppressed
Ozempic	Semaglutide	22	suppressed
Prednisone	Prednisone	22	19
Valacyclovir	Valacyclovir Hcl	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Pregabalin	Pregabalin	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Econazole Nitrate	Econazole Nitrate	17	suppressed
Lidocaine	Lidocaine	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Azithromycin	Azithromycin	16	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Temazepam	Temazepam	16	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Baclofen	Baclofen	14	suppressed
Carvedilol	Carvedilol	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Letrozole	Letrozole	14	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	14	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	14	suppressed
Tramadol Hcl	Tramadol Hcl	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Glipizide	Glipizide	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Valsartan	Valsartan	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Nyamyc	Nystatin	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error